Infertility, Female Clinical Trial
— endoMBOfficial title:
Difference in Relative Abundance of Lactobacillus in Endometrium With and Without Histologically Proven Chronic Endometritis
Infertile women undergoing hysteroscopy for diagnostic or therapeutic indication are asked to
donate a sample of endometrium.
Endometrial samples of study participants are examined for signs of chronic endometritis by
immunohistochemical analysis.
High-throughput sequencing of the microbial 16s ribosomal ribonucleic acid (rRNA) subunit is
performed to identify and quantify the microbes present in the sample.
Obstetric and reproductive outcome is recorded 12 months after hysteroscopy (telephone
interview).
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Infertile (= 12 months of unprotected regular intercourse) premenopausal women or women with = 2 consecutive miscarriages undergoing hysteroscopy. - Infertile women undergoing office hysteroscopy for other reasons, such as suspected intrauterine adhesions after curettage, irregular endometrium, uterine polyps, repeated implantation failure in assisted reproduction, etc. - Signed informed consent - BMI = 18 kg/m2 and = 40 kg/m2 - Age: = 18 years and = 45 years - follicle stimulating hormone (FSH) = 20 (day 2-5 and estradiol = 300 pmol/l) Exclusion Criteria: - Treatment with antibiotics in the past 3 months - Treatment with immune-suppressing or immune-modulating drugs in the past 3 months - Treatment with estrogens, progestins, contraceptives and/or antiestrogenic drugs in the cycle during which hysteroscopy is performed - Current infection of the cervix with Chlamydia trachomatis and/or gonorrhea - Pelvic surgery in the past 3 months - Suspicion of malignancy - Pregnancy - Breast feeding - Perimenopause (irregular menses and FSH = 20 U/l on day 3-5 of the cycle) - Outdated endometrial sample from the luteal phase (this criterion will be evaluated during visit 4 post surgery) - Elevated progesterone concentration = 20 nmol/l measured in the blood sample taken at the time of HSC. - Insufficient amount of tissue for immunohistochemical analysis and/or microbial 16s rRNA gene sequencing |
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Basel | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quantity of Lactobacillus | Quantity of Lactobacillus determined by 16S ribosomal RNA gene sequencing | 1 year | |
Primary | alpha diversity of microbes | Quantification of microbes and their diversity within the individual endometrium sample | 1 year | |
Primary | Shannon index (Beta diversity) | Comparison of microbial diversity among the subjects | 1 Year | |
Secondary | Pregnancy Rate | Number of pregnancies within 12 months after hysteroscopy | 2 years | |
Secondary | Live Birth Rate | Number of pregnancies within 12 months after hysteroscopy | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05969574 -
Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
|
||
Recruiting |
NCT05358483 -
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Completed |
NCT03177538 -
Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders
|
Phase 4 | |
Completed |
NCT03638856 -
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
|
N/A | |
Completed |
NCT04052464 -
The Study of the Implantation Window From Endometrial Biopsy With Gene Expression Methods
|
||
Withdrawn |
NCT04753736 -
Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC
|
N/A | |
Completed |
NCT03349905 -
Deferred Versus Fresh Embryo Transfers
|
N/A | |
Completed |
NCT05076981 -
Progesterone Levels During Ovulation and Luteal Phase
|
||
Completed |
NCT04096027 -
Cabergoline Before or After Oocyte Collection for Follicular Resolution
|
Phase 4 | |
Recruiting |
NCT05980091 -
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
|
Phase 1 | |
Terminated |
NCT01933633 -
Improved Fertility After Exercise in Overweight/Obese Women
|
N/A | |
Terminated |
NCT01202643 -
Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF
|
Phase 1/Phase 2 | |
Completed |
NCT01202656 -
Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)
|
Phase 1/Phase 2 | |
Completed |
NCT01408615 -
A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)
|
||
Enrolling by invitation |
NCT05698550 -
The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
|
Phase 3 | |
Not yet recruiting |
NCT03910582 -
Personalized FET in RIF Patients With Displaced Dating
|
N/A | |
Completed |
NCT05440019 -
Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration
|
||
Completed |
NCT05130125 -
Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer
|